ANHUI HONGYU WUZHOU Medical Manufacturer (SZ:301234) Xin Lang Cai Jing·2025-10-31 01:00Core Viewpoint - Wuzhou Medical, a leading ODM supplier of disposable medical devices in China, has reported lower-than-average revenue and net profit in the industry, indicating potential challenges in market competitiveness [2]. Group 1: Company Overview - Wuzhou Medical was established on April 15, 2011, and was listed on the Shenzhen Stock Exchange on July 5, 2022. The company is headquartered in Anqing, Anhui Province [1]. - The company specializes in the research, production, and sales of disposable sterile infusion medical devices and other related medical supplies, primarily serving foreign medical device brands through an "ODM + integrated supply" model [1]. Group 2: Financial Performance - For Q3 2025, Wuzhou Medical reported a revenue of 345 million yuan, ranking 40th out of 50 in the industry, significantly lower than the top competitor, Yingke Medical, which reported 7.425 billion yuan [2]. - The company's net profit for the same period was 18.51 million yuan, ranking 41st in the industry, again far below the leading player, Lepu Medical, which reported 996 million yuan [2]. - The asset-liability ratio for Q3 2025 was 12.32%, slightly higher than the previous year's 11.87% but lower than the industry average of 23.66% [2]. - The gross profit margin for Q3 2025 was 14.22%, down from 17.37% in the previous year and significantly below the industry average of 48.78% [2]. Group 3: Management and Shareholder Information - The chairman, Huang Fan, received a salary of 1.0238 million yuan in 2024, a decrease of 661,400 yuan from 2023 [3]. - The number of A-share shareholders decreased by 17.56% to 4,986 as of September 30, 2025, with the average number of circulating A-shares held per shareholder dropping by 28.34% [3].